更新版 GOLD 指南对疫苗接种、肺一氧化碳弥散量（DLCO）和肺癌筛查提出新的指导
慢性阻塞性肺疾病全球倡议（Global Initiative for Chronic Obstructive Lung Disease, GOLD）已发布 2022 版 COPD 诊断、治疗和预防综合报告。更新信息包括：
现场使用 DLCO 检测进行诊断
一项系统评价显示，与安慰剂相比，COPD 药物治疗可降低 FEV1 下降率达 5.0 mL/年。
美国疾病预防控制中心（CDC）更新版疫苗接种建议提出：所有 COPD 患者接受 2019 冠状病毒病（coronavirus disease 2019, COVID-19）疫苗接种，50 岁以上人群接受水痘-带状疱疹疫苗接种
建议对因吸烟导致的 COPD 患者，每年进行低剂量 CT 扫描筛查肺癌（与美国预防服务工作组建议一致）。
小结
定义
病史和体格检查
诊断性检查
治疗流程
撰稿人
作者
Manoochehr Abadian Sharifabad, MD
Fountain Valley Regional Medical Center
Fountain Valley
CA
利益声明
MAS declares that he has no competing interests.
鸣谢
Dr Manoochehr Abadian Sharifabad would like to gratefully acknowledge Dr Jonathan P. Parsons and Dr Michael Ezzie, the previous contributors to this topic. JPP has contributed at speakers' bureaus for GlaxoSmithKline, Inc., Schering-Plough, Inc., and AstraZeneca, Inc.
利益声明
ME declares that he has no competing interests.
同行评议者
Hormoz Ashtyani, MD, FCCP
Hackensack University Medical Center
Hackensack
NJ
利益声明
HA declares that he has no competing interests.
William Janssen, MD
Assistant Professor of Medicine
National Jewish Medical and Research Center
University of Colorado Health Sciences Center
Denver
CO
利益声明
WJ declares that he has no competing interests.
Francis Thien, MD, FRACP, FCCP
Associate Professor
Director of Respiratory Medicine
Eastern Health & Monash University
Victoria
Australia
利益声明
FT declares that he has no competing interests.
内容使用需遵循免责声明